General Information of DFM (ID: F23621)
Name
Amikacin 590 mg/8.4 ml injectable
Company
Insmed orporated
Active Pharmaceutical Ingredient (API) Amikacin API Info click to show the detail info of this API
Approved
Drug Inactive Ingredient (DIGs)
DIG ID DIG Info DIG Name DIG Functional Class
E0TT7O DIG Info 1,2-Distearoyl-sn-glycero-3-phosphocholine Other agent
E0S1ZN DIG Info Cholesterol Emollient ...
E0T4TW DIG Info Sodium chloride Diluent ...
E0L2PN DIG Info Sodium hydroxide Alkalizing agent
E0H2SC DIG Info Water Solvent
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM
      Oxidoreductase (ORase)
            DBT Name: Sterol 14-alpha demethylase (CYP51A1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity IC50 > 200000 nM (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP51A_HUMAN
      Transferase (TFase)
            DBT Name: DNA polymerase alpha (POLA) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity IC50 > 500000 nM (tested by experiment) [2]
                    Tested Species Homo sapiens (Human)
                    UniProt ID DPOLA_HUMAN
            DBT Name: DNA polymerase beta (POLB) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity IC50 > 500000 nM (tested by experiment) [2]
                    Tested Species Rattus norvegicus (Rat)
                    UniProt ID DPOLB_RAT
      Lyase/isomerase/ligase (L/I/G)
            DBT Name: DNA topoisomerase II (TOP2) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity IC50 > 500000 nM (tested by experiment) [2]
                    Tested Species Homo sapiens (Human)
                    UniProt ID TOP2A_HUMAN ; TOP2B_HUMAN
      Nuclear receptor (NR)
            DBT Name: Androgen receptor (AR) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity IC50 > 42657.95 nM (tested by experiment) [3]
                    Tested Species Rattus norvegicus (Rat)
                    UniProt ID ANDR_RAT
            DBT Name: Nuclear receptor ROR-gamma (RORC) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Cholesterol
                    Biological Activity EC50 = 20 nM (tested by experiment) [4]
                    Tested Species Homo sapiens (Human)
                    UniProt ID RORG_HUMAN
References
1 Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. Drug Metab Dispos. 2007 Mar; 35(3):493-500.
2 Molecular design of cholesterols as inhibitors of DNA polymerase alpha. J Med Chem. 2004 Sep 23; 47(20):4971-4.
3 Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals. J Med Chem. 2005 Sep 8; 48(18):5666-74.
4 Retinoic Acid Receptor-Related Orphan Receptor t (RORt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy. J Med Chem. 2018 Jul 26; 61(14):5794-5804.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.